The following corporate finance-related stories were reported by media: * The United States will take new steps on Friday to limit the access of major Russian banks, including Sberbank, to U.S. debt and equity markets to punish Russia for its intervention in Ukraine, sources familiar with the matter said.* U.S. specialty drugmaker Akorn Inc is exploring a bid for Belgian drugmaker UCB SA's U.S. subsidiary, a deal that would allow the company to move its tax domicile overseas in a practice known as inversion, according to people familiar with the matter.
Akorn, Inc. (Akom) is a manufacturer and markets a full line of diagnostic and therapeutic ophthalmic pharmaceuticals, as well as niche hospital drugs and injectable pharmaceuticals. Shares of AKRX traded higher by 3.36% or $1.23/share to $37.85. In the past year, the shares have traded as low as $18.11 and as high as $39.48. On average, 1210320 shares of AKRX exchange hands on a given day and today's volume is recorded at 2445668.
Source
